Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7871462 | 0.92 | ADRB3 (0.48) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7874038 | 0.91 | CYP3A4 (0.49) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7881452 | 0.90 | ADRB3 (0.42) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7872924 | 0.90 | CTSB (0.43) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL13071638 | 0.85 | CYP3A4 (0.37) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL13071414 | 0.85 | CYP3A4 (0.38) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7878560 | 0.85 | ADRB3 (0.49) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7873166 | 0.84 | ADRB3 (0.48) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7880592 | 0.84 | ADRB3 (0.48) | ADRB3ADRA2BADRA2CCYP3A4CTSB | |
| SCHEMBL7874274 | 0.84 | ADRB3 (0.49) | ADRB3ADRA2BADRA2CCYP3A4CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009142842-A9 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2010-11-25 | — | — | WO | disclosed |
| WO-2009142842-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2009-11-26 | — | — | WO | disclosed |